ConductScience.org, home

Paper16557282

Protein-tyrosine phosphatases and cancer.

Ostman A and 2 others. Nat Rev Cancer, 2006. Cited by 548 papers, by iCite.

Cite this record

ConductScience Library. Protein-tyrosine phosphatases and cancer. Papers, record 16557282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16557282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Protein-tyrosine phosphatases and cancer.
PubMed
Journal
Nat Rev Cancer
PubMed
Year
2006
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
548
iCite
Relative citation ratio, by iCite
10.6
iCite
Revised in PubMed
2022-08-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ostman AArne
2Hellberg CCarina
3Böhmer FDFrank D

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
Protein Tyrosine PhosphatasesMajor topic
Animals
ErbB Receptors
Humans
Phosphorylation
Tyrosine

Source PubMed

Download CSV of topics

Cited by329

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 548 citations.

PMIDTitleJournalYearIn PapersSource
42451698Vismodegib Exerts a Pleotropic Effect on Topotecan-Resistant and Sensitive Ovarian Cancer Cell Lines in 2D and 3D Cell Culture Models.Molecules2026https://conductscience.org/library/papers/42451698PubMed
42423920Multicomponent reactions for protein tyrosine phosphatase inhibitors.Mol Divers2026https://conductscience.org/library/papers/42423920PubMed
42212130Single-cell and spatial transcriptomic profiling reveals the expression characteristics of PTPRR in epithelial cells and its potential implications in pancreatic cancer metastasis.Front Immunol2026https://conductscience.org/library/papers/42212130PubMed
42072080Hepatic ACSL4 Loss Boosts Endogenous Gamma-Glutamylcysteine to Alleviate Alcoholic Liver Disease.Antioxidants (Basel)2026https://conductscience.org/library/papers/42072080PubMed
41808249Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors.Cancer Res Commun2026https://conductscience.org/library/papers/41808249PubMed
41718985Golgi Retention and Oncogenic Signaling of KIT Tyrosine Kinase in Gastrointestinal Stromal Tumor.Subcell Biochem2026https://conductscience.org/library/papers/41718985PubMed
41559020The R451 site is critical for PTPN18 to exert tumor suppressive effects in breast cancer through the negative regulatory interacting protein fibrillarin.Cell Death Dis2026https://conductscience.org/library/papers/41559020PubMed
41557758Pervanadate-induced oxidation relieves autoinhibition of the protein tyrosine kinase SRC.Sci Signal2026https://conductscience.org/library/papers/41557758PubMed
41486293Targeting PTPN13 with 11-amino-acid peptides of C-terminal APC prevents immune evasion of colorectal cancer.Cell Res2026https://conductscience.org/library/papers/41486293PubMed
41327349Genome-wide association study of lung function decline using elastic-net regression: a prospective analysis in Korean cohort.Hum Genomics2025https://conductscience.org/library/papers/41327349PubMed
41154495The Redox Paradox: Cancer's Double-Edged Sword for Malignancy and Therapy.Antioxidants (Basel)2025https://conductscience.org/library/papers/41154495PubMed
40864347Tissue-specific profiling of human protein phosphatases identifies G6PC1 as a liver cancer-selective biomarker.Discov Oncol2025https://conductscience.org/library/papers/40864347PubMed
40355891Protein tyrosine phosphatase receptor type kappa (PTPRK) revisited: evolving insights into structure, function, and pathology.J Transl Med2025https://conductscience.org/library/papers/40355891PubMed
40341216PRL-3: unveiling a new horizon in cancer therapy.Acta Pharmacol Sin2025https://conductscience.org/library/papers/40341216PubMed
40260019SHP099-containing multi-targeting hydrogel promotes rapid skin reconstruction through modulating a variety of cells.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/40260019PubMed
40140631Malignant JAK-signaling: at the interface of inflammation and malignant transformation.Leukemia2025https://conductscience.org/library/papers/40140631PubMed
40073865Proteome-wide assessment of differential missense variant clustering in neurodevelopmental disorders and cancer.Cell Genom2025https://conductscience.org/library/papers/40073865PubMed
40016288PTPRO represses breast cancer lung metastasis by inhibiting the JAK2-YAP axis.Sci Rep2025https://conductscience.org/library/papers/40016288PubMed
39906260Oncogenic FLT3 internal tandem duplications (ITD) and CD45/PTPRC control osteoclast functions and bone microarchitecture.JBMR Plus2025https://conductscience.org/library/papers/39906260PubMed
39794316Targeting Shp2 as a therapeutic strategy for neurodegenerative diseases.Transl Psychiatry2025https://conductscience.org/library/papers/39794316PubMed

See all 329 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PTPN115781PubTator's text mininghttps://conductscience.org/library/genes/5781

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16557282

GET https://conductscience.org/api/papers/v1/16557282/cited_by?page=2